Showing results (171-180 of 291) with videos related to

Sort By:
Pageof 30
The Journal of Experimental Medicine|August 2, 2006
The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosisChang-Il Suh, Natalie D Stull, Xing Jun Li, et al.
Nature|July 11, 2008
Polo-like kinase-1 is activated by aurora A to promote checkpoint recoveryLibor Macůrek, Arne Lindqvist, Dan Lim, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Cell Cycle (Georgetown, Tex.)|February 21, 2013
Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitorsDavid M Weingeist, Jing Ge, David K Wood, et al.
The EMBO Journal|April 21, 2007
Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrateDrew M Lowery, Karl R Clauser, Majbrit Hjerrild, et al.
The Journal of Cell Biology|February 28, 2002
14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transportAnne Brunet, Fumihiko Kanai, Justine Stehn, et al.
Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
World Journal of Emergency Surgery : WJES|April 22, 2020
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisRashikh Choudhury, Christopher D Barrett, Hunter B Moore, et al.
Pageof 30